207 related articles for article (PubMed ID: 19811316)
1. Molecular mechanisms of viral immune evasion proteins to inhibit MHC class I antigen processing and presentation.
Zhou F
Int Rev Immunol; 2009; 28(5):376-93. PubMed ID: 19811316
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation.
Zhou F
Int Rev Immunol; 2009; 28(3-4):239-60. PubMed ID: 19811323
[TBL] [Abstract][Full Text] [Related]
3. Viral immune evasion molecules attack the ER peptide-loading complex and exploit ER-associated degradation pathways.
Lybarger L; Wang X; Harris M; Hansen TH
Curr Opin Immunol; 2005 Feb; 17(1):71-8. PubMed ID: 15653314
[TBL] [Abstract][Full Text] [Related]
4. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of MHC class I-restricted antigen processing and cross-presentation.
Cresswell P; Ackerman AL; Giodini A; Peaper DR; Wearsch PA
Immunol Rev; 2005 Oct; 207():145-57. PubMed ID: 16181333
[TBL] [Abstract][Full Text] [Related]
6. Pathways of antigen processing and presentation.
Watts C; Powis S
Rev Immunogenet; 1999; 1(1):60-74. PubMed ID: 11256573
[TBL] [Abstract][Full Text] [Related]
7. Inhibition by woodchuck hepatitis virus of class I major histocompatibility complex presentation on hepatocytes is mediated by virus envelope pre-S2 protein and can be reversed by treatment with gamma interferon.
Wang J; Michalak TI
J Virol; 2006 Sep; 80(17):8541-53. PubMed ID: 16912304
[TBL] [Abstract][Full Text] [Related]
8. Viral interference with MHC class I antigen presentation pathway: the battle continues.
Ambagala AP; Solheim JC; Srikumaran S
Vet Immunol Immunopathol; 2005 Aug; 107(1-2):1-15. PubMed ID: 15978672
[TBL] [Abstract][Full Text] [Related]
9. Cross-presentation: underlying mechanisms and role in immune surveillance.
Rock KL; Shen L
Immunol Rev; 2005 Oct; 207():166-83. PubMed ID: 16181335
[TBL] [Abstract][Full Text] [Related]
10. Expression of hepatitis C virus proteins does not interfere with major histocompatibility complex class I processing and presentation in vitro.
Moradpour D; Grabscheid B; Kammer AR; Schmidtke G; Groettrup M; Blum HE; Cerny A
Hepatology; 2001 May; 33(5):1282-7. PubMed ID: 11343257
[TBL] [Abstract][Full Text] [Related]
11. Viral modulation of antigen presentation: manipulation of cellular targets in the ER and beyond.
Lilley BN; Ploegh HL
Immunol Rev; 2005 Oct; 207():126-44. PubMed ID: 16181332
[TBL] [Abstract][Full Text] [Related]
12. New insights into the structure of the MHC class I peptide-loading complex and mechanisms of TAP inhibition by viral immune evasion proteins.
Praest P; Liaci AM; Förster F; Wiertz EJHJ
Mol Immunol; 2019 Sep; 113():103-114. PubMed ID: 29606337
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo.
Farrell HE; Vally H; Lynch DM; Fleming P; Shellam GR; Scalzo AA; Davis-Poynter NJ
Nature; 1997 Apr; 386(6624):510-4. PubMed ID: 9087412
[TBL] [Abstract][Full Text] [Related]
14. Herpesviruses and immunity: the art of evasion.
Griffin BD; Verweij MC; Wiertz EJ
Vet Microbiol; 2010 Jun; 143(1):89-100. PubMed ID: 20303681
[TBL] [Abstract][Full Text] [Related]
15. MHC class I alleles and their exploration of the antigen-processing machinery.
Groothuis TA; Griekspoor AC; Neijssen JJ; Herberts CA; Neefjes JJ
Immunol Rev; 2005 Oct; 207():60-76. PubMed ID: 16181327
[TBL] [Abstract][Full Text] [Related]
16. MHC class I antigen presentation--recently trimmed and well presented.
Flutter B; Gao B
Cell Mol Immunol; 2004 Feb; 1(1):22-30. PubMed ID: 16212917
[TBL] [Abstract][Full Text] [Related]
17. Trypanosoma cruzi infection does not impair major histocompatibility complex class I presentation of antigen to cytotoxic T lymphocytes.
Buckner FS; Wipke BT; Van Voorhis WC
Eur J Immunol; 1997 Oct; 27(10):2541-8. PubMed ID: 9368608
[TBL] [Abstract][Full Text] [Related]
18. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
[TBL] [Abstract][Full Text] [Related]
19. Analysis of subcellular organelles involved in major histocompatibility complex (MHC) class II-restricted antigen presentation by electrophoresis.
Engering A; Lefkovits I; Pieters J
Electrophoresis; 1997 Dec; 18(14):2523-30. PubMed ID: 9527480
[TBL] [Abstract][Full Text] [Related]
20. The immunogenic potential of human fetal retinal pigment epithelium and its relation to transplantation.
Rezai KA; Semnani RT; Patel SC; Ernest JT; van Seventer GA
Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2662-71. PubMed ID: 9375586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
